Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 3Glioma 3Wilms Tumor 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Xanthogranuloma, Juvenile 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Lymphoma, Follicular 1Histiocytic Sarcoma 1Chondrosarcoma 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Biliary Tract Neoplasms 1Anemia, Refractory, with Excess of Blasts 1AML 1

Interventions

Filgrastim 4Ifosfamide 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Immune Checkpoint Inhibitors 2Etoposide 2spartalizumab 1regorafenib 1perifosine 1pegfilgrastim 1pazopanib 1ivosidenib 1etoposide phosphate 1enasidenib 1drozitumab 1angiotensin I (1-7) 1alanosine 1abemaciclib 1Vincristine 1Trabectedin 1Topotecan 1Thiotepa 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiotherapy 1Radiosurgery 1Proton Therapy 1Pharmacogenomic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Chondrosarcoma × ivosidenib × Clear all
NCT04278781 2026-04-23

AG-120 in People With IDH1 Mutant Chondrosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
6 enrolled
LymphoidSarcoma

Chondrosarcoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡